These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

814 related items for PubMed ID: 12850760

  • 1. [Epidemiology of HIV-associated malignancies].
    Launay O, Guillevin L.
    Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
    [Abstract] [Full Text] [Related]

  • 2. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S, Gill MJ.
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [Abstract] [Full Text] [Related]

  • 3. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE, Kaplan LD.
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [Abstract] [Full Text] [Related]

  • 4. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S, Swiss HIV Cohort.
    J Natl Cancer Inst; 2005 Mar 16; 97(6):425-32. PubMed ID: 15770006
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
    Barbaro G, Barbarini G.
    Oncol Rep; 2007 May 16; 17(5):1121-6. PubMed ID: 17390054
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human immunodeficiency virus-associated neoplasms: epidemiology, pathogenesis, and review of current therapy.
    Aboulafia DM.
    Cancer Pract; 1994 May 16; 2(4):297-306. PubMed ID: 7858657
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of HAART on HIV-linked malignancies.
    Laurence J.
    AIDS Read; 2003 May 16; 13(5):202, 205. PubMed ID: 12800820
    [No Abstract] [Full Text] [Related]

  • 19. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, Costagliola D, Salmon D, Chêne G, Morlat P.
    Cancer; 2004 Jul 15; 101(2):317-24. PubMed ID: 15241829
    [Abstract] [Full Text] [Related]

  • 20. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future.
    Engels EA, Goedert JJ.
    J Natl Cancer Inst; 2005 Mar 16; 97(6):407-9. PubMed ID: 15769998
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.